1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University.
4Beijing Key Laboratory of Translational Medicine for Cerebrovascular Disease; and.
J Neurosurg. 2018 Jun;128(6):1785-1791. doi: 10.3171/2017.2.JNS162405. Epub 2017 Aug 11.
OBJECTIVE The optimal surgical modality for moyamoya disease (MMD) remains unclear. The aim of this study was to compare the surgical effects of direct bypass (DB) and indirect bypass (IB) in the treatment of adult ischemic-type MMD. METHODS Adult patients with ischemic-type MMD who underwent either DB or IB from 2009 to 2015 were identified retrospectively from a prospective database. Patients lost to follow-up or with a follow-up period less than 12 months were excluded. Recurrent stroke events and modified Rankin Scale (mRS) scores at the last follow-up were compared between the 2 surgical groups after 1:1 propensity score matching. RESULTS A total of 220 patients were considered, including 143 patients who underwent DB and 77 patients who underwent IB. After propensity score matching, 70 pairs were obtained. The median follow-up period was 40.5 months (range 14-75 months) in the DB group and 31.5 months (range 14-71 months) in the IB group (p = 0.004). Kaplan-Meier analysis showed that patients who received DB had a longer stroke-free time (mean 72.1 months) compared with patients who received IB (mean 61.0 months) (p = 0.045). Good neurological status (mRS score ≤ 2) was achieved in 64 patients in the DB group (91.4%) and 66 patients in the IB group (94.3%), but there was no significant difference (p = 0.512). CONCLUSIONS Although neurological function outcome was not determined by the surgical modality, DB is more effective in preventing recurrent ischemic strokes than IB for adult ischemic-type MMD.
对于烟雾病(MMD),最佳的手术方式仍不明确。本研究旨在比较直接旁路(DB)和间接旁路(IB)治疗成人缺血型 MMD 的手术效果。
从前瞻性数据库中回顾性地确定了 2009 年至 2015 年间接受 DB 或 IB 的成人缺血型 MMD 患者。排除失访或随访时间不足 12 个月的患者。在 1:1 倾向评分匹配后,比较两组患者在最后一次随访时的复发性卒中事件和改良 Rankin 量表(mRS)评分。
共纳入 220 例患者,其中 143 例行 DB,77 例行 IB。经过倾向评分匹配后,获得了 70 对患者。DB 组的中位随访时间为 40.5 个月(范围 14-75 个月),IB 组为 31.5 个月(范围 14-71 个月)(p = 0.004)。Kaplan-Meier 分析显示,接受 DB 的患者无卒中时间(平均 72.1 个月)长于接受 IB 的患者(平均 61.0 个月)(p = 0.045)。DB 组有 64 例(91.4%)和 IB 组有 66 例(94.3%)患者的神经功能状态良好(mRS 评分≤2),但无显著差异(p = 0.512)。
尽管手术方式未决定神经功能结局,但对于成人缺血型 MMD,DB 在预防复发性缺血性卒中方面比 IB 更有效。